PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence. Zhan H, Antony VM, Tang H, Theriot J, et al. Breast Cancer Res Treat 2025 Mar 10. doi: 10.1007/s10549-025-07660.

Read + Share

Amedeo Smart

Independent Medical Education

Zhan H, Antony VM, Tang H, Theriot J, et al. PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence. Breast Cancer Res Treat 2025 Mar 10. doi: 10.1007/s10549-025-07660.
PMID: 40063317